IQVIA Holdings | IQV - Current Assets


IQVIA Holdings reported $6.45B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Accenture USD 31.83B 2.89B Jun/2026
Agilent USD 4.69B 70M Jun/2026
Bruker USD 2.16B 67.9M Sep/2026
Cardinal Health USD 40.99B 2.24B Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Cigna USD 47.23B 241M Sep/2026
Cognizant Technology Solutions USD 8.09B 531M Sep/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
CVS Health USD 79.39B 4.05B Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.98B 50M Sep/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Elevance Health USD 68.52B 1.34B Sep/2026
Humana USD 39.61B 477M Sep/2026
IBM USD 31.19B 2.79B Sep/2026
Illumina USD 3.04B 201M Sep/2026
Infosys INR 1.06T 1.06T Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Laboratory Of America USD 3.97B 151.3M Sep/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
McKesson USD 66.68B 3.85B Sep/2026
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pharma Mar EUR 295.56M 14.62M Sep/2026
Publicis EUR 22.49B 575M Jun/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Tilray USD 729.32M 28.18M Sep/2025
UnitedHealth USD 85.6B 1.27B Sep/2026
Veeva Systems USD 7.95B 117.03M Jun/2026
Veradigm USD 679.65M 131.12M Dec/2022
Waters USD 3.9B 186M Jun/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026